An Investigation of the Incidence and Time to Onset of Adverse Events Associated with Eslicarbazepine Acetate Adjunct Treatment: An Integrated Analysis of Two Double-Blind Placebo-Controlled Trials
AuthID
P-002-BDD
P-002-BDD